ACUTE MYELOID LEUKAEMIA (AML)
Clinical trials for ACUTE MYELOID LEUKAEMIA (AML) explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKAEMIA (AML) trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKAEMIA (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo targets stubborn leukemia remnants
Disease control Not yet recruitingThis study tests whether combining sorafenib and venetoclax can eliminate tiny amounts of leukemia that remain after initial treatment (called measurable residual disease, or MRD). About 87 adults with acute myeloid leukemia (AML) will receive this drug pair. The goal is to see i…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: PHASE2, PHASE3 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated May 26, 2026 09:35 UTC
-
Lifeline for cancer patients: rollover study extends access to promising drug
Disease control Not yet recruitingThis study offers continued access to the experimental drug RVU120 for up to 10 adults with advanced solid tumors, acute myeloid leukemia, or high-risk myelodysplastic syndrome who are already benefiting from it in an earlier study. Participants must have completed at least 5 tre…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: PHASE2 • Sponsor: Ryvu Therapeutics SA • Aim: Disease control
Last updated May 26, 2026 09:32 UTC
-
New blood test may personalize leukemia treatment, avoiding harsh chemo
Disease control Not yet recruitingThis study tests a new blood test (5hmC) to see how well acute myeloid leukemia (AML) is responding to treatment. About 112 adults with newly diagnosed AML will get either a milder drug (hypomethylating agent) or standard strong chemo. The test helps doctors decide if more treatm…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated May 20, 2026 11:55 UTC